Dealcast is a fortnightly podcast from the Dealreporter and Activistmonitor teams covering M&A, ECM and activism.
The Italian market is put under the microscope in this week's podcast. Dealreporter's Giulia Lasgni tells Julie-Anna Needham that improved sentiment is helping deal and ECM activity.
Deane McRobie explains what is slowing down Creat Group's acquisition of Biotest. The US foreign investment committee CFIUS is taking a close look but why has its remit expanded?
Dealcast: The M&A Podcast